TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
R$90.54
0.00%
(0.00) 1D
Okt 6, 3:21:39 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa TAKP34...
Mkt. cap
59.62B
Avg. na dami
36.00
Dami
0.00
Mataas nang 52-wk
R$102.65
Mababa nang 52-wk
R$70.80
Mga natitirang share
1.60B
Bilang ng mga empleyado
47K
Mkt. cap
59.62B
Avg. na dami
36.00
Dami
0.00
Mataas nang 52-wk
R$102.65
Mababa nang 52-wk
R$70.80
Mga natitirang share
1.60B
Bilang ng mga empleyado
47K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
1 oras ang nakalipas
Takeda stock pre-market at EUR 16.55
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Tungkol sa Takeda Pharmaceutical Co Ltd BDR
CEOChristophe Weber | Christophe Weber
Mga Empleyado47K
ItinatagHun 12, 1781
Headquarters-
Sektor-
Websitetakeda.com